News Author: Andrew D. Bowser Publish date: October 15, 2018
Fecal blood test outreach and patient navigation have robust evidence to show they improve colorectal cancer screening rates, results ...
News Author: Andrew D. Bowser Publish date: October 15, 2018
SAN ANTONIO—Patients with pulmonary embolism (PE) have a lower mortality risk if they are obese, according to a retrospective analysis of nearly 2 mil...
News Author: Andrew D. Bowser Publish date: October 14, 2018
The introduction of antiangiogenic agents is likely one key factor that led to the mortality decrease.
News Author: Andrew D. Bowser Publish date: October 13, 2018
The median age at diagnosis for these cancers was 45 years in the ongoing Nurses Health Study II.
News Author: Andrew D. Bowser Publish date: October 12, 2018
Survival outcomes for patients with stage III renal cell carcinoma and nodal involvement are comparable with patients with stage IV disease.
Video Author: Andrew D. Bowser Publish date: October 12, 2018
Health care providers may harbor implicit, or unconscious, biases that contribute to health care disparities.
News Author: Andrew D. Bowser Publish date: October 12, 2018
Dupilumab, a fully human anti–IL-4Ra monoclonal antibody, resulted in lower rates of severe asthma exacerbation.
News Author: Andrew D. Bowser Publish date: October 12, 2018
SAN ANTONIO – Computed tomography may be is overused for evaluation of pulmonary embolism.
News Author: Andrew D. Bowser Publish date: October 12, 2018
Bacteremic sepsis during acute lymphoblastic leukemia (ALL) treatment may contribute to neurocognitive dysfunction later in life, results of a cohort ...
News Author: Andrew D. Bowser Publish date: October 11, 2018
SAN ANTONIO – Triple therapy reduced time to first moderate/severe COPD exacerbation when compared with dual therapy.
News Author: Andrew D. Bowser Publish date: October 11, 2018
SAN ANTONIO – Make sure guidelines are being closely followed before telling parents to consider getting rid of the family pet.
News Author: Andrew D. Bowser Publish date: October 10, 2018
The anti-IL-6 antibody siltuximab is central to first-line treatment of idiopathic multicentric Castleman disease (iMCD), according to new guidelines ...
News Author: Andrew D. Bowser Publish date: October 9, 2018
SAN ANTONIO – The obese patients in the analysis had a lower mortality risk, despite receiving more thrombolytics.
Video Author: Andrew D. Bowser Publish date: October 9, 2018
SAN ANTONIO – Ventilator-dependent patient are especially vulnerable during natural disasters.
News Author: Andrew D. Bowser Publish date: October 9, 2018
SAN ANTONIO – LABA/LAMA has been found to have cardiovascular benefits in hyperinflated patients with COPD.
